In these modules genes such as EEF1A1, RPS27, RPL7A, RPL30, RPLP0, RPL3 and RPL14 were predicted as novel prognostic or diagnostic biomarkers and new therapeutic target in CAD. This evidence concerns the gene RPL7A and coronary artery disorder.